Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?

Ying Yang Liao; Jian Hong Zhong; Ning Fu Peng; Le Qun Li; Tie Jun Tong

doi:10.1111/liv.13208

Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?

Ying Yang Liao
, Jian Hong Zhong
, Ning Fu Peng
, Le Qun Li
, Tie Jun Tong

Department of Mathematics

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	1715
Number of pages	1
Journal	Liver International
Volume	36
Issue number	11
DOIs	https://doi.org/10.1111/liv.13208
Publication status	Published - 1 Nov 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/liv.13208

Cite this

@article{293249182f8d4c8990cd594940727f7e,

title = "Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?",

author = "Liao, \{Ying Yang\} and Zhong, \{Jian Hong\} and Peng, \{Ning Fu\} and Li, \{Le Qun\} and Tong, \{Tie Jun\}",

year = "2016",

month = nov,

day = "1",

doi = "10.1111/liv.13208",

language = "English",

volume = "36",

pages = "1715",

journal = "Liver International",

issn = "1478-3223",